Diagnostic and classification criteria, clinical and functional assessment, and therapeutic advances for spondyloarthropathies

Ignazio Olivieri, Fabrizio Cantini, Carlo Salvarani

Research output: Contribution to journalArticle

Abstract

Two sets of criteria have been proposed and widely accepted in the last few years for the classification of the whole spectrum of spondyloarthropathy, including the undifferentiated forms. These classification criteria - the Amor criteria and the European Spondyloarthropathy Study Group criteria - are not, however, particularly helpful for diagnosis because they do not include the milder and monosymptomatic forms. Outcomes research in spondyloarthritis is growing, and new instruments have been suggested. An international study group of experts is working to propose a core set of measures to be included in future clinical trials on ankylosing spondylitis. Intrasynovial corticosteroid injections in the sacroiliac joints may represent a valid alternative for patients with inflammatory low back pain that is unresponsive to nonsteroidal anti-inflammatory drugs. Sulfasalazine is an effective therapy for the psoriatic arthritis and peripheral arthritis of ankylosing spondylitis. A recent study has suggested its efficacy in reactive arthritis as well. In reactive arthritis, the use of long-term antibiotic therapy has been proposed and is under study.

Original languageEnglish
Pages (from-to)284-290
Number of pages7
JournalCurrent Opinion in Rheumatology
Volume9
Issue number4
DOIs
Publication statusPublished - 1997

Fingerprint

Spondylarthropathies
Reactive Arthritis
Ankylosing Spondylitis
Sacroiliac Joint
Sulfasalazine
Psoriatic Arthritis
Low Back Pain
Arthritis
Adrenal Cortex Hormones
Anti-Inflammatory Agents
Outcome Assessment (Health Care)
Clinical Trials
Anti-Bacterial Agents
Injections
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

Diagnostic and classification criteria, clinical and functional assessment, and therapeutic advances for spondyloarthropathies. / Olivieri, Ignazio; Cantini, Fabrizio; Salvarani, Carlo.

In: Current Opinion in Rheumatology, Vol. 9, No. 4, 1997, p. 284-290.

Research output: Contribution to journalArticle

@article{5edeebd43311450dbc0d2d091a7aec73,
title = "Diagnostic and classification criteria, clinical and functional assessment, and therapeutic advances for spondyloarthropathies",
abstract = "Two sets of criteria have been proposed and widely accepted in the last few years for the classification of the whole spectrum of spondyloarthropathy, including the undifferentiated forms. These classification criteria - the Amor criteria and the European Spondyloarthropathy Study Group criteria - are not, however, particularly helpful for diagnosis because they do not include the milder and monosymptomatic forms. Outcomes research in spondyloarthritis is growing, and new instruments have been suggested. An international study group of experts is working to propose a core set of measures to be included in future clinical trials on ankylosing spondylitis. Intrasynovial corticosteroid injections in the sacroiliac joints may represent a valid alternative for patients with inflammatory low back pain that is unresponsive to nonsteroidal anti-inflammatory drugs. Sulfasalazine is an effective therapy for the psoriatic arthritis and peripheral arthritis of ankylosing spondylitis. A recent study has suggested its efficacy in reactive arthritis as well. In reactive arthritis, the use of long-term antibiotic therapy has been proposed and is under study.",
author = "Ignazio Olivieri and Fabrizio Cantini and Carlo Salvarani",
year = "1997",
doi = "10.1097/00002281-199707000-00002",
language = "English",
volume = "9",
pages = "284--290",
journal = "Current Opinion in Rheumatology",
issn = "1040-8711",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Diagnostic and classification criteria, clinical and functional assessment, and therapeutic advances for spondyloarthropathies

AU - Olivieri, Ignazio

AU - Cantini, Fabrizio

AU - Salvarani, Carlo

PY - 1997

Y1 - 1997

N2 - Two sets of criteria have been proposed and widely accepted in the last few years for the classification of the whole spectrum of spondyloarthropathy, including the undifferentiated forms. These classification criteria - the Amor criteria and the European Spondyloarthropathy Study Group criteria - are not, however, particularly helpful for diagnosis because they do not include the milder and monosymptomatic forms. Outcomes research in spondyloarthritis is growing, and new instruments have been suggested. An international study group of experts is working to propose a core set of measures to be included in future clinical trials on ankylosing spondylitis. Intrasynovial corticosteroid injections in the sacroiliac joints may represent a valid alternative for patients with inflammatory low back pain that is unresponsive to nonsteroidal anti-inflammatory drugs. Sulfasalazine is an effective therapy for the psoriatic arthritis and peripheral arthritis of ankylosing spondylitis. A recent study has suggested its efficacy in reactive arthritis as well. In reactive arthritis, the use of long-term antibiotic therapy has been proposed and is under study.

AB - Two sets of criteria have been proposed and widely accepted in the last few years for the classification of the whole spectrum of spondyloarthropathy, including the undifferentiated forms. These classification criteria - the Amor criteria and the European Spondyloarthropathy Study Group criteria - are not, however, particularly helpful for diagnosis because they do not include the milder and monosymptomatic forms. Outcomes research in spondyloarthritis is growing, and new instruments have been suggested. An international study group of experts is working to propose a core set of measures to be included in future clinical trials on ankylosing spondylitis. Intrasynovial corticosteroid injections in the sacroiliac joints may represent a valid alternative for patients with inflammatory low back pain that is unresponsive to nonsteroidal anti-inflammatory drugs. Sulfasalazine is an effective therapy for the psoriatic arthritis and peripheral arthritis of ankylosing spondylitis. A recent study has suggested its efficacy in reactive arthritis as well. In reactive arthritis, the use of long-term antibiotic therapy has been proposed and is under study.

UR - http://www.scopus.com/inward/record.url?scp=0030873601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030873601&partnerID=8YFLogxK

U2 - 10.1097/00002281-199707000-00002

DO - 10.1097/00002281-199707000-00002

M3 - Article

C2 - 9229173

AN - SCOPUS:0030873601

VL - 9

SP - 284

EP - 290

JO - Current Opinion in Rheumatology

JF - Current Opinion in Rheumatology

SN - 1040-8711

IS - 4

ER -